Evaluation of antidiabetic activity of the seeds of Swietenia macrophylla in diabetic rats

Pharmaceutical Biology

Volumn 47, Issue 2, 2009, Pages 132-136

  Maiti, Anup ^a   Dewanjee, Saikat ^a   Kundu, Mintu ^a   Mandal, Subhash C ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Antihyperglycemic; Normoglycemic; OGTT; Streptozotocin; Swietenia macrophylla

Indexed keywords

CHOLESTEROL; GLIBENCLAMIDE; GLUCOSE; GLYCOGEN; METHANOL; PLANT EXTRACT; STREPTOZOCIN; SWIETENIA MACROPHYLLA EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; MALE; MELIACEAE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PLANT SEED; RAT; STREPTOZOCIN DIABETES; SWIETENIA MACROPHYLLA; TRIACYLGLYCEROL BLOOD LEVEL;

MELIACEAE; RATTUS; SWIETENIA MACROPHYLLA;

EID: 70749125801     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200802436703     Document Type: Article

References (17)

1. Balkau B, Charles MA, Eschwege E (2000): Discussion epidemologigue des nouveaux criteres du diabetes. Mt Endocrionologie 2: 229-234.
2. Bonner-Weir S (1988): Morphological evidence of pancreatic polarity of beta cells within islets of Langerhans. Diabetes 37: 616-621.
3. Caroll NV, Longley RW, Roe JH (1956): The determination of glycogen in liver and muscle by use of anthron reagent. J Biol Chem 220: 583-593.
4. Chase PH, Glasgow AM (1976): Juvenile diabetes mellitus and serum lipid and lipoprotein levels. Am J Dis Child 130: 1113-1117.
5. Guevera AP, Apilado A, Sakarai H, Kozuka M, Tokunda H (1996): Anti-inflammatory, antimutagenecity and antitumor activity of mahagony seeds Swietenia macrophylla (Meliaceae). Phill J Sc 125: 271-278.
6. Guha Sircar SSG, Chakraborty T (1951): Tetranortriterpenoid from Swietenia macrophylla. J Ind Chem Soc 28: 207-211.
7. Karunanayake EH, Hearse DJ, Mellows G (1974): The synthesis of 14C streptozotocin and its distribution and excretion in rat. Biochem J 142: 673-685.
8. Kuyvenhoven GP, Meinders AE (1999): Oxidative stress and diabetes mellitus pathogenesis of long term complications. Eur J Int Med 10: 9-19.
9. Latner A (1958): Carbohydrate metabolism, abnormalities of post absorbtive blood sugar level. Clinical Biochemistry. Philadelphia, WB Saunders, p. 48.
10. Leslie RDG, Elliott RB (1994): Early environmental events as a cause of IDDM. Diabetes 43: 843-850.
11. Mandal SC, Mukharjee PK, Saha K, Das J, Pal M, Saha BP (1997): Hypoglycaemic activity of Ficus racemosa L. (Moraceae) leaves in streptozotocin induced diabetic rats. Nat Prod Sci 3 (1): 38-41.
12. Mootoo BS, Allisha A, Motilal R, Pingal R, Ramlal A, Khan A, Reynolds WF, McLean S (1999): Limonoids from Swietenia macrophylla and S. aubrevilleana. J Nat Prod 62: 1514-1517.
13. Palmer AM, Thomas CR, Gopaul N, Dhir S, Anggared EE, Poston L, Tribe RM (1998): Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function in small mesenteric arteries of the streptozotocin diabetic rats. Diabetologia 41: 148-156.
14. PHS (Public Health Service) (1986): Public Health Service Policy on Human Care and Laboratory Animals. Washington, D. C., U. S., Department of Health and Human Services. Available from office for protection from Research Risks, Building 31, Room 4B09, NIII, Bethesda, MD 20892.
15. Shirwaikar A, Rajendran K, Kumar CD (2004): Oral antidiabetic activity of Annoa squamosa extract in NIDDM rats. Pharm Biol 24: 30-35.
16. Siddque M, Sun Y, Lin JC, Chien YW (1987): Facilitated transdermal transport of insulin. J Pharm Sci 76: 341-345.
17. Swanston Flatt SK, Day C, Bailey CJ, Flatt PR (1990): Traditional plant treatments for diabetes: Studies in normal and streptozotocin diabetic mice. Diabetologia 33: 462-464.